Lesogaberan’s potential efficacy in non-alcoholic steatohepatitis (NASH) was tested in human stellate cells, human precision cut liver slices, and in vivo in a well-validated murine model of NASH.
[Scientific Reports]
7992332
{7992332:DDDDDDDD}
apa
50
1
168065
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
